Last updated on November 2019

A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989


Find a site near you

Start Over

Inquest Clinical Research /ID# 165694

Baytown, TX United States
5.44miles
  Connect »